| r&d systems 产品目录--泽浩公司 |
| r&d systems 产品目录列表 page 5 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
| 产品编号 |
产品描述 |
规格/包装 |
品牌 |
| 413-ml-025 |
recombinant mouse il-13 (25 ug) |
25 ug |
r&d systems |
| 413-ml-025/cf |
recombinant mouse il-13, cf (25 ug) |
25 ug |
r&d systems |
| 4140-me-050 |
recombinant canine hgf r/c-met/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 414-cs-005 |
recombinant mouse g-csf (5 ug) |
5 ug |
r&d systems |
| 414-cs-005/cf |
recombinant mouse g-csf, cf (5 ug) |
5 ug |
r&d systems |
| 414-cs-025 |
recombinant mouse g-csf (25 ug) |
25 ug |
r&d systems |
| 414-cs-025/cf |
recombinant mouse g-csf, cf (25 ug) |
25 ug |
r&d systems |
| 4150-pp-050 |
recombinant human active pp2c alpha/ppm1a, cf (50 ug) |
50 ug |
r&d systems |
| 415-ml-010 |
recombinant mouse gm-csf (10 ug) |
10 ug |
r&d systems |
| 415-ml-010/cf |
recombinant mouse gm-csf, cf (10 ug) |
10 ug |
r&d systems |
| 415-ml-050 |
recombinant mouse gm-csf (50 ug) |
50 ug |
r&d systems |
| 415-ml-050/cf |
recombinant mouse gm-csf, cf (50 ug) |
50 ug |
r&d systems |
| 416-ml-010/cf |
recombinant mouse m-csf, cf (10 ug) |
10 ug |
r&d systems |
| 416-ml-050/cf |
recombinant mouse m-csf, cf (50 ug) |
50 ug |
r&d systems |
| 417-ml-005 |
recombinant mouse il-10 (5 ug) |
5 ug |
r&d systems |
| 417-ml-005/cf |
recombinant mouse il-10, cf (5 ug) |
5 ug |
r&d systems |
| 417-ml-025 |
recombinant mouse il-10 (25 ug) |
25 ug |
r&d systems |
| 417-ml-025/cf |
recombinant mouse il-10, cf (25 ug) |
25 ug |
r&d systems |
| 418-ml-005 |
recombinant mouse il-11 (5 ug) |
5 ug |
r&d systems |
| 418-ml-005/cf |
recombinant mouse il-11, cf (5 ug) |
5 ug |
r&d systems |
| 418-ml-025 |
recombinant mouse il-11 (25 ug) |
25 ug |
r&d systems |
| 418-ml-025/cf |
recombinant mouse il-11, cf (25 ug) |
25 ug |
r&d systems |
| 419-ml-010 |
recombinant mouse il-12 (10 ug) |
10 ug |
r&d systems |
| 419-ml-010/cf |
recombinant mouse il-12, cf (10 ug) |
10 ug |
r&d systems |
| 419-ml-050 |
recombinant mouse il-12 (50 ug) |
50 ug |
r&d systems |
| 419-ml-050/cf |
recombinant mouse il-12, cf (50 ug) |
50 ug |
r&d systems |
| 4206-b7-100 |
recombinant mouse b7-h4/fc chimera, cf |
100 µg |
r&d systems |
| 4207-dm-025 |
recombinant human dmc/vcc-1 |
25 µg |
r&d systems |
| 4207-dm-025 |
recombinant human dmc/vcc-1 (25 ug) |
25 ug |
r&d systems |
| 4207-dm-025/cf |
recombinant human dmc/vcc-1, cf |
25 µg |
r&d systems |
| 4207-dm-025/cf |
recombinant human dmc/vcc-1, cf (25 ug) |
25 ug |
r&d systems |
| 4208-nx-050 |
recombinant rat neurexophilin 1/nxph1, cf |
50 µg |
r&d systems |
| 4208-nx-050 |
recombinant rat neurexophilin 1/nxph1, cf (50 ug) |
50 ug |
r&d systems |
| 4209-fc-050 |
recombinant human ficolin-1, cf |
50 µg |
r&d systems |
| 420-me-020 |
recombinant mouse ccl11/eotaxin (20 ug) |
20 ug |
r&d systems |
| 420-me-020/cf |
recombinant mouse ccl11/eotaxin, cf (20 ug) |
20 ug |
r&d systems |
| 420-me-100 |
recombinant mouse ccl11/eotaxin (100 ug) |
100 ug |
r&d systems |
| 420-me-100/cf |
recombinant mouse ccl11/eotaxin, cf (100 ug) |
100 ug |
r&d systems |
| 4218-ut-050 |
recombinant human uteroglobin, cf |
50 µg |
r&d systems |
| 421-ml-025 |
recombinant mouse il-17 (25 ug) |
25 ug |
r&d systems |
| 421-ml-025/cf |
recombinant mouse il-17, cf (25 ug) |
25 ug |
r&d systems |
| 4234-zn-010 |
recombinant human psma/folh1, cf |
10 µg |
r&d systems |
| 4234-zn-010 |
recombinant human psma/folh1, cf (10 ug) |
10 ug |
r&d systems |
| 4237-sr-050 |
recombinant mouse sorcs2, cf |
50 µg |
r&d systems |
| 423-f8-025 |
recombinant mouse fgf-8b (25 ug) |
25 ug |
r&d systems |
| 423-f8-025/cf |
recombinant mouse fgf-8b, cf (25 ug) |
25 ug |
r&d systems |
| 4245-ad-020 |
recombinant human adamts13, cf |
20 µg |
r&d systems |
| 424-fc-025 |
recombinant mouse fgf-8c (25 ug) |
25 ug |
r&d systems |
| 424-fc-025/cf |
recombinant mouse fgf-8c, cf (25 ug) |
25 ug |
r&d systems |
| 425-r1-050 |
recombinant mouse stnf ri/tnfrsf1a (50 ug) |
50 ug |
r&d systems |
| 425-r1-050/cf |
recombinant mouse soluble tnf ri/tnfrsf1a, cf (50 ug) |
50 ug |
r&d systems |
| 426-r2-050 |
recombinant mouse stnf rii/tnfrsf1b (50 ug) |
50 ug |
r&d systems |
| 426-r2-050/cf |
recombinant mouse soluble tnf rii/tnfrsf1b, cf (50 ug) |
50 ug |
r&d systems |
| 4270-dm-025 |
recombinant mouse dmc/vcc-1 |
25 µg |
r&d systems |
| 4270-dm-025 |
recombinant mouse dmc/vcc-1 |
25 µg |
r&d systems |
| 4270-dm-025/cf |
recombinant mouse dmc/vcc-1, cf |
25 µg |
r&d systems |
| 4270-dm-025/cf |
recombinant mouse dmc/vcc-1, cf |
25 µg |
r&d systems |
| 427-fl-005/cf |
recombinant mouse flt-3 ligand, cf (5 ug) |
5 ug |
r&d systems |
| 427-fl-025/cf |
recombinant mouse flt-3 ligand, cf (25 ug) |
25 ug |
r&d systems |
| 4289-eg-025 |
recombinant human pro-egf (25 ug) |
25 ug |
r&d systems |
| 4289-eg-025 |
recombinant human pro-egf (aa 21-1023) |
25 µg |
r&d systems |
| 4289-eg-025/cf |
recombinant human pro-egf (aa 21-1023), cf |
25 µg |
r&d systems |
| 4289-eg-025/cf |
recombinant human pro-egf, cf (25 ug) |
25 ug |
r&d systems |
| 428-p5-025 |
recombinant mouse ccl12/mcp-5 (25 ug) |
25 ug |
r&d systems |
| 428-p5-025/cf |
recombinant mouse ccl12/mcp-5, cf (25 ug) |
25 ug |
r&d systems |
| 4290-s4-050 |
recombinant human igsf4d, cf |
50 µg |
r&d systems |
| 4294-mr-050 |
recombinant mouse il-22 r, cf |
50 µg |
r&d systems |
| 4294-mr-050 |
recombinant mouse il-22 r, cf (50 ug) |
50 ug |
r&d systems |
| 4295-kr-025 |
recombinant rat kremen-2, cf |
25 µg |
r&d systems |
| 4296-lr-050 |
recombinant human lrpap, cf |
50 µg |
r&d systems |
| 4296-lr-050 |
recombinant human lrpap, cf (50 ug) |
50 ug |
r&d systems |
| 4297-mg-050 |
recombinant mouse mgl1, cf |
50 µg |
r&d systems |
| 4297-mg-050 |
recombinant mouse mgl1, cf (50 ug) |
50 ug |
r&d systems |
| 4298-np-050 |
recombinant mouse nephronectin, cf |
50 µg |
r&d systems |
| 429-fr-100 |
recombinant mouse gfr alpha-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 4306-ms-010 |
recombinant human msp (cys 672 ala) |
10 µg |
r&d systems |
| 4306-ms-010 |
recombinant human msp (cys 672 ala) (10 ug) |
10 ug |
r&d systems |
| 4306-ms-010/cf |
recombinant human msp (cys 672 ala), cf |
10 µg |
r&d systems |
| 4306-ms-010/cf |
recombinant human msp (cys 672 ala), cf (10 ug) |
10 ug |
r&d systems |
| 4307-ad-020 |
recombinant human adamts4, cf |
20 µg |
r&d systems |
| 4308-se-010 |
recombinant human prolyl oligopeptidase/prep, cf |
10 µg |
r&d systems |
| 430-ri-050 |
recombinant mouse tnf ri/tnfrsf1a/fc chimera (50 ug) |
50 ug |
r&d systems |
| 430-ri-050/cf |
recombinant mouse tnf ri/tnfrsf1a/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 4318-pr-050 |
recombinant mouse pilr-alpha, cf |
50 µg |
r&d systems |
| 431-ms-100 |
recombinant mouse msp r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 4325-fc-050 |
recombinant human fc gamma riiia/cd16a, cf |
50 µg |
r&d systems |
| 4326-rg-050 |
recombinant rat igf-i, cf |
50 µg |
r&d systems |
| 4327-sa-050 |
recombinant human s100a13, cf |
50 µg |
r&d systems |
| 4328-sa-050 |
recombinant mouse s100a13, cf |
50 µg |
r&d systems |
| 4329-eg-025 |
recombinant mouse egfl6, cf |
25 µg |
r&d systems |
| 432-b3-200 |
recombinant mouse ephb3/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 433-mc-025 |
recombinant mouse lix (25 ug) |
25 ug |
r&d systems |
| 433-mc-025/cf |
recombinant mouse lix, cf (25 ug) |
25 ug |
r&d systems |
| 434-ct-200 |
recombinant mouse ctla-4/fc chimera (200 ug) |
200 ug |
r&d systems |
| 434-ct-200/cf |
recombinant mouse ctla-4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 4359-da-050 |
recombinant human histone deacetylase 8, cf |
50 µg |
r&d systems |
| 435-fa-050 |
recombinant mouse fas/tnfrsf6/fc chimera (50 ug) |
50 ug |
r&d systems |
| 435-fa-050/cf |
recombinant mouse fas (cd95)/tnfrsf6/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 4376-tg-050 |
recombinant human transglutaminase 2/tgm2, cf |
50 µg |
r&d systems |
| 437-mr-100 |
recombinant mouse bmpr-ia/alk-3/fc chimera (100 ug) |
100 ug |
r&d systems |
| 437-mr-100/cf |
recombinant mouse bmpr-ia/alk-3/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 4384-cd-050 |
recombinant human cdo, cf |
50 µg |
r&d systems |
| 4385-cd-050 |
recombinant human cd109, cf |
50 µg |
r&d systems |
| 4386-dm-050 |
recombinant mouse dmp-1, cf |
50 µg |
r&d systems |
| 4387-er-050 |
recombinant mouse erbb4/fc chimera, cf |
50 µg |
r&d systems |
| 4387-er-050 |
recombinant mouse erbb4/fc chimera, cf |
50 µg |
r&d systems |
| 4388-mr-050 |
recombinant mouse il-20 r beta/fc chimera, cf |
50 µg |
r&d systems |
| 4389-or-050 |
recombinant human osm r beta/fc chimera, cf |
50 µg |
r&d systems |
| 438-ct-010 |
recombinant mouse cardiotrophin-1 (ct-1) (10 ug) |
10 ug |
r&d systems |
| 438-ct-010/cf |
recombinant mouse cardiotrophin-1 (ct-1), cf (10 ug) |
10 ug |
r&d systems |
| 438-ct-050 |
recombinant mouse cardiotrophin-1 (ct-1) (50 ug) |
50 ug |
r&d systems |
| 438-ct-050/cf |
recombinant mouse cardiotrophin-1 (ct-1), cf (50 ug) |
50 ug |
r&d systems |
| 4394-as-050 |
recombinant human asgpr1, cf |
50 µg |
r&d systems |
| 4394-as-050 |
recombinant human asgpr1, cf |
50 µg |
r&d systems |
| 4395-sr-050 |
recombinant mouse sorcs1, cf |
50 µg |
r&d systems |
| 4395-sr-050 |
recombinant mouse sorcs1, cf (50 ug) |
50 ug |
r&d systems |
| 4397-en-010 |
recombinant human cd39/entpd1, cf |
10 µg |
r&d systems |
| 4397-en-010 |
recombinant human cd39/entpd1, cf |
10 µg |
r&d systems |
| 4398-en-010 |
recombinant mouse cd39/entpd1, cf |
10 µg |
r&d systems |
| 4398-en-010 |
recombinant mouse cd39/entpd1, cf |
10 µg |
r&d systems |
| 4399-en-010 |
recombinant human cd39l2/entpd6, cf |
10 µg |
r&d systems |
| 439-md-025 |
recombinant mouse ccl22/mdc (25 ug) |
25 ug |
r&d systems |
| 439-md-025/cf |
recombinant mouse ccl22/mdc, cf (25 ug) |
25 ug |
r&d systems |
| 4400-en-010 |
recombinant human cd39l3/entpd3, cf |
10 µg |
r&d systems |
| 440-m3-025 |
recombinant mouse ccl19/mip-3 beta (25 ug) |
25 ug |
r&d systems |
| 440-m3-025/cf |
recombinant mouse ccl19/mip-3 beta, cf (25 ug) |
25 ug |
r&d systems |
| 4415-su-010 |
recombinant human arylsulfatase b/arsb, cf |
10 µg |
r&d systems |
| 4416-ad-020 |
recombinant human adam12, cf |
20 µg |
r&d systems |
| 441-op-050 |
recombinant mouse osteopontin (opn) (50 ug) |
50 ug |
r&d systems |
| 441-op-050/cf |
recombinant mouse osteopontin (opn), cf (50 ug) |
50 ug |
r&d systems |
| 441-op-200 |
recombinant mouse osteopontin (opn) (200 ug) |
200 ug |
r&d systems |
| 441-op-200/cf |
recombinant mouse osteopontin (opn), cf (200 ug) |
200 ug |
r&d systems |
| 442-lk-002 |
recombinant mouse cxcl15/lungkine (2 ug) |
2 ug |
r&d systems |
| 4434-ck-025 |
recombinant rat ccl27/ctack |
25 µg |
r&d systems |
| 4434-ck-025/cf |
recombinant rat ccl27/ctack, cf |
25 µg |
r&d systems |
| 4435-bd-050 |
recombinant human beta-defensin 3, cf |
50 µg |
r&d systems |
| 4436-dn-050 |
recombinant mouse dnam-1/fc chimera, cf |
50 µg |
r&d systems |
| 4437-il-025 |
recombinant rat il-17f |
25 µg |
r&d systems |
| 4437-il-025 |
recombinant rat il-17f |
25 µg |
r&d systems |
| 4437-il-025/cf |
recombinant rat il-17f, cf |
25 µg |
r&d systems |
| 4437-il-025/cf |
recombinant rat il-17f, cf |
25 µg |
r&d systems |
| 443-kd-050 |
recombinant mouse vegf r2/flk-1/fc chimera (50 ug) |
50 ug |
r&d systems |
| 443-kd-050/cf |
recombinant mouse vegf r2/flk-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 4444-tr-050 |
recombinant human thrombopoietin r, cf |
50 µg |
r&d systems |
| 444-bns-100 |
recombinant mouse bmpr-ib/alk-6/fc chimera (nso) (100 ug) |
100 ug |
r&d systems |
| 444-bns-100/cf |
recombinant mouse bmpr-ib/alk-6/fc chimera (nso), cf (100 ug) |
100 ug |
r&d systems |
| 4460-mg-100 |
recombinant mouse igg2a fc, cf |
100 µg |
r&d systems |
| 446-b4-200 |
recombinant mouse ephb4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 447-ml-010 |
recombinant mouse il-15 (10 ug) |
10 ug |
r&d systems |
| 447-ml-010/cf |
recombinant mouse il-15, cf (10 ug) |
10 ug |
r&d systems |
| 4480-lr-050 |
recombinant mouse lrpap, cf |
50 µg |
r&d systems |
| 4481-mr-100 |
recombinant mouse il-17 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 4484-n2-050 |
recombinant human neuregulin-2/nrg2, cf |
50 µg |
r&d systems |
| 4485-nx-050 |
recombinant rat neurexin 1 alpha/nrxn1a, cf |
50 µg |
r&d systems |
| 4486-sb-050 |
recombinant human sirp gamma/cd172g/fc chimera, cf |
50 µg |
r&d systems |
| 4487-an-050 |
recombinant human angiopoietin-like 4, cf |
50 µg |
r&d systems |
| 4488-en-010 |
recombinant mouse 5'-nucleotidase/cd73, cf |
10 µg |
r&d systems |
| 4490-hp-050 |
recombinant human hemopexin, cf |
50 µg |
r&d systems |
| 4494-ah-010 |
recombinant human asahl, cf |
10 µg |
r&d systems |
| 450-ma-010 |
recombinant mouse ccl3/mip-1 alpha (10 ug) |
10 ug |
r&d systems |
| 450-ma-010/cf |
recombinant mouse ccl3/mip-1 alpha, cf (10 ug) |
10 ug |
r&d systems |
| 450-ma-050 |
recombinant mouse ccl3/mip-1 alpha (50 ug) |
50 ug |
r&d systems |
| 450-ma-050/cf |
recombinant mouse ccl3/mip-1 alpha, cf (50 ug) |
50 ug |
r&d systems |
| 4516-zn-010 |
recombinant rat ace-2, cf |
10 µg |
r&d systems |
| 4517-se-010 |
recombinant mouse neutrophil elastase/ela2, cf |
10 µg |
r&d systems |
| 4518-rb-050 |
recombinant mouse erbb3/fc chimera, cf |
50 µg |
r&d systems |
| 451-mb-010 |
recombinant mouse ccl4/mip-1 beta (10 ug) |
10 ug |
r&d systems |
| 451-mb-010/cf |
recombinant mouse ccl4/mip-1 beta, cf (10 ug) |
10 ug |
r&d systems |
| 451-mb-050 |
recombinant mouse ccl4/mip-1 beta (50 ug) |
50 ug |
r&d systems |
| 451-mb-050/cf |
recombinant mouse ccl4/mip-1 beta, cf (50 ug) |
50 ug |
r&d systems |
| 4520-gp-050 |
recombinant mouse glypican 1, cf |
50 µg |
r&d systems |
| 4529-hb-050 |
recombinant mouse habp1/c1qbp, cf |
50 µg |
r&d systems |
| 452-m2-010 |
recombinant mouse mip-2 (10 ug) |
10 ug |
r&d systems |
| 452-m2-010/cf |
recombinant mouse mip-2, cf (10 ug) |
10 ug |
r&d systems |
| 452-m2-050 |
recombinant mouse mip-2 (50 ug) |
50 ug |
r&d systems |
| 452-m2-050/cf |
recombinant mouse mip-2, cf (50 ug) |
50 ug |
r&d systems |
| 453-kc-010 |
recombinant mouse kc (10 ug) |
10 ug |
r&d systems |
| 453-kc-010/cf |
recombinant mouse kc, cf (10 ug) |
10 ug |
r&d systems |
| 453-kc-050 |
recombinant mouse kc (50 ug) |
50 ug |
r&d systems |
| 453-kc-050/cf |
recombinant mouse kc, cf (50 ug) |
50 ug |
r&d systems |
| 4540-ks-010 |
recombinant human active raf-1 (y340e y341e, 306-end), cf |
10 µg |
r&d systems |
| 4544-ns-050 |
recombinant human insl3, cf |
50 µg |
r&d systems |
| 4546-sa-050 |
recombinant human sirp alpha/cd172a, cf |
50 µg |
r&d systems |
| 454-a8-200 |
recombinant mouse epha8/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 4556-se-010 |
recombinant mouse coagulation factor xi, cf |
10 µg |
r&d systems |
| 4557-pi-010 |
recombinant mouse cystatin f, cf |
10 µg |
r&d systems |
| 455-mc-010 |
recombinant mouse scf (10 ug) |
10 ug |
r&d systems |
| 455-mc-010/cf |
recombinant mouse scf, cf (10 ug) |
10 ug |
r&d systems |
| 455-mc-050 |
recombinant mouse scf (50 ug) |
50 ug |
r&d systems |
| 455-mc-050/cf |
recombinant mouse scf, cf (50 ug) |
50 ug |
r&d systems |
| 456-mc-010 |
recombinant mouse ccl7/marc (10 ug) |
10 ug |
r&d systems |
| 456-mc-010/cf |
recombinant mouse ccl7/marc, cf (10 ug) |
10 ug |
r&d systems |
| 456-mc-050 |
recombinant mouse ccl7/marc (50 ug) |
50 ug |
r&d systems |
| 456-mc-050/cf |
recombinant mouse ccl7/marc, cf (50 ug) |
50 ug |
r&d systems |
| 457-6c-025 |
recombinant mouse ccl21/6ckine (25 ug) |
25 ug |
r&d systems |
| 457-6c-025/cf |
recombinant mouse ccl21/6ckine, cf (25 ug) |
25 ug |
r&d systems |
| 458-mf-025 |
recombinant mouse cx3cl1/fractalkine (chemokine domain) (25 ug) |
25 ug |
r&d systems |
| 458-mf-025/cf |
recombinant mouse cx3cl1/fractalkine (chemokine domain), cf (25 ug) |
25 ug |
r&d systems |
| 459-mo-100 |
recombinant mouse osteoprotegerin/tnfrsf11b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 4600-su-010 |
recombinant mouse arylsulfatase g/arsg, cf |
10 µg |
r&d systems |
| 4604-tg-050 |
recombinant human transglutaminase 3/tgm3, cf |
50 µg |
r&d systems |
| 460-sd-010 |
recombinant mouse cxcl12/sdf-1 alpha (10 ug) |
10 ug |
r&d systems |
| 460-sd-010/cf |
recombinant mouse cxcl12/sdf-1 alpha, cf (10 ug) |
10 ug |
r&d systems |
| 460-sd-050 |
recombinant mouse cxcl12/sdf-1 alpha (50 ug) |
50 ug |
r&d systems |
| 460-sd-050/cf |
recombinant mouse cxcl12/sdf-1 alpha, cf (50 ug) |
50 ug |
r&d systems |
| 4610-th-010 |
recombinant human tsh alpha/beta |
10 µg |
r&d systems |
| 461-sh-025 |
recombinant mouse sonic hedgehog, n-terminus (shh-n) (25 ug) |
25 ug |
r&d systems |
| 461-sh-025/cf |
recombinant mouse sonic hedgehog, n-terminus (shh-n), cf (25 ug) |
25 ug |
r&d systems |
| 4628-sf-050 |
recombinant mouse cracc/slamf7, cf |
50 µg |
r&d systems |
| 4629-dp-050 |
recombinant human dermatopontin, cf |
50 µg |
r&d systems |
| 462-tec-010 |
recombinant mouse trance/rank l/tnfsf11 (e. coli-expressed) (10 ug) |
10 ug |
r&d systems |
| 462-tec-010/cf |
recombinant mouse trance/rank l/tnfsf11 (e. coli), cf (10 ug) |
10 ug |
r&d systems |
| 462-tr-010 |
recombinant mouse trance/rank l/tnfsf11 (10 ug) |
10 ug |
r&d systems |
| 462-tr-010/cf |
recombinant mouse trance/rank l/tnfsf11, cf (10 ug) |
10 ug |
r&d systems |
| 4630-dc-050 |
recombinant human desmocollin-3, cf |
50 µg |
r&d systems |
| 4635-ml-025 |
recombinant mouse il-28a/ifn-lambda 2 |
25 µg |
r&d systems |
| 4635-ml-025/cf |
recombinant mouse il-28a/ifn-lambda 2, cf |
25 µg |
r&d systems |
| 4636-nl-050 |
recombinant mouse noelin-1, cf |
50 µg |
r&d systems |
| 463-mg-025 |
recombinant mouse ccl9/10/mip-1 gamma (25 ug) |
25 ug |
r&d systems |
| 463-mg-025/cf |
recombinant mouse ccl9/10/mip-1 gamma, cf (25 ug) |
25 ug |
r&d systems |
| 4644-vs-010 |
recombinant human vegf 121 (aa 207-327) |
10 µg |
r&d systems |
| 4644-vs-010/cf |
recombinant human vegf 121 (aa 207-327) |
10 µg |
r&d systems |
| 464-sh-025 |
recombinant mouse sonic hedgehog (c25ii) n-terminus (25 ug) |
25 ug |
r&d systems |
| 464-sh-025/cf |
recombinant mouse sonic hedgehog (c25ii) n-terminus, cf (25 ug) |
25 ug |
r&d systems |
| 465-pl-010 |
recombinant mouse plgf-2 (10 ug) |
10 ug |
r&d systems |
| 465-pl-010/cf |
recombinant mouse plgf-2, cf (10 ug) |
10 ug |
r&d systems |
| 465-pl-050 |
recombinant mouse plgf-2 (50 ug) |
50 ug |
r&d systems |
| 465-pl-050/cf |
recombinant mouse plgf-2, cf (50 ug) |
50 ug |
r&d systems |
| 466-cr-010 |
recombinant mouse cxcl10/ip-10/crg-2 (10 ug) |
10 ug |
r&d systems |
| 466-cr-010/cf |
recombinant mouse cxcl10/ip-10/crg-2, cf (10 ug) |
10 ug |
r&d systems |
| 466-cr-050 |
recombinant mouse cxcl10/ip-10/crg-2 (50 ug) |
50 ug |
r&d systems |
| 466-cr-050/cf |
recombinant mouse cxcl10/ip-10/crg-2, cf (50 ug) |
50 ug |
r&d systems |
| 467-b2-200 |
recombinant mouse ephb2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 4687-cl-050 |
recombinant mouse cl-k1/colec11, cf |
50 µg |
r&d systems |
| 468-mg-100 |
recombinant mouse gp130/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 4694-s4-050 |
recombinant human semaphorin 4a/fc chimera, cf |
50 µg |
r&d systems |
| 469-vd-025 |
recombinant mouse vegf-d (25 ug) |
25 ug |
r&d systems |
| 469-vd-025/cf |
recombinant mouse vegf-d, cf (25 ug) |
25 ug |
r&d systems |
| 470-bc-025 |
recombinant mouse cxcl13/blc/bca-1 (25 ug) |
25 ug |
r&d systems |
| 470-bc-025/cf |
recombinant mouse cxcl13/blc/bca-1, cf (25 ug) |
25 ug |
r&d systems |
| 4710-ac-050 |
recombinant mouse cd157, cf |
50 µg |
r&d systems |
| 4714-zn-020 |
recombinant human methionine aminopeptidase 1d, cf |
20 µg |
r&d systems |
| 471-f1-100 |
recombinant mouse vegf r1/flt-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 472-ff-025 |
recombinant mouse cx3cl1/fractalkine (full length) (25 ug) |
25 ug |
r&d systems |
| 472-ff-025/cf |
recombinant mouse cx3cl1/fractalkine (full length), cf (25 ug) |
25 ug |
r&d systems |
| 4736-ac-050 |
recombinant human cd157, cf |
50 µg |
r&d systems |
| 473-eb-200 |
recombinant mouse ephrin-b1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 4749-mr-050 |
recombinant human mis rii/fc chimera, cf |
50 µg |
r&d systems |
| 474-mr-025 |
recombinant mouse il-10 sr alpha (25 ug) |
25 ug |
r&d systems |
| 474-mr-025/cf |
recombinant mouse il-10 sr alpha, cf (25 ug) |
25 ug |
r&d systems |
| 4750-rg-050 |
recombinant canine rage, cf |
50 µg |
r&d systems |
| 4754-sr-050 |
recombinant mouse scara5, cf |
50 µg |
r&d systems |
| 4778-cr-010 |
recombinant variola crmb |
10 µg |
r&d systems |
| 4778-cr-010/cf |
recombinant variola crmb, cf |
10 µg |
r&d systems |
| 477-mn-025 |
recombinant mouse neurturin (25 ug) |
25 ug |
r&d systems |
| 477-mn-025/cf |
recombinant mouse neurturin, cf (25 ug) |
25 ug |
r&d systems |
| 478-mr-025 |
recombinant mouse ccl5/rantes (25 ug) |
25 ug |
r&d systems |
| 478-mr-025/cf |
recombinant mouse ccl5/rantes, cf (25 ug) |
25 ug |
r&d systems |
| 479-je-010 |
recombinant mouse ccl2/je/mcp-1 (10 ug) |
10 ug |
r&d systems |
| 479-je-010/cf |
recombinant mouse ccl2/je/mcp-1, cf (10 ug) |
10 ug |
r&d systems |
| 479-je-050 |
recombinant mouse ccl2/je/mcp-1 (50 ug) |
50 ug |
r&d systems |
| 479-je-050/cf |
recombinant mouse ccl2/je/mcp-1, cf (50 ug) |
50 ug |
r&d systems |
| 480-rm-010 |
recombinant mouse il-1ra/il-1f3 (10 ug) |
10 ug |
r&d systems |
| 480-rm-010/cf |
recombinant mouse il-1ra/il-1f3, cf (10 ug) |
10 ug |
r&d systems |
| 480-rm-050 |
recombinant mouse il-1ra/il-1f3 (50 ug) |
50 ug |
r&d systems |
| 480-rm-050/cf |
recombinant mouse il-1ra/il-1f3, cf (50 ug) |
50 ug |
r&d systems |
| 481-tk-025 |
recombinant mouse ccl25/teck (25 ug) |
25 ug |
r&d systems |
| 481-tk-025/cf |
recombinant mouse ccl25/teck, cf (25 ug) |
25 ug |
r&d systems |
| 482-rt-100 |
recombinant mouse ret/fc chimera (100 ug) |
100 ug |
r&d systems |
| 482-rt-100/cf |
recombinant mouse ret/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 483-cd-200 |
recombinant mouse cd28/fc chimera (200 ug) |
200 ug |
r&d systems |
| 483-cd-200/cf |
recombinant mouse cd28/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 485-mi-100/cf |
recombinant mouse ifn-gamma, cf (100 ug) |
100 ug |
r&d systems |
| 486-lt-025 |
recombinant mouse xcl1/lymphotactin (25 ug) |
25 ug |
r&d systems |
| 486-lt-025/cf |
recombinant mouse xcl1/lymphotactin, cf (25 ug) |
25 ug |
r&d systems |
| 487-c-010 |
recombinant mouse ccl6/c10 (10 ug) |
10 ug |
r&d systems |
| 487-c-010/cf |
recombinant mouse ccl6/c10, cf (10 ug) |
10 ug |
r&d systems |
| 487-c-050 |
recombinant mouse ccl6/c10 (50 ug) |
50 ug |
r&d systems |
| 487-c-050/cf |
recombinant mouse ccl6/c10, cf (50 ug) |
50 ug |
r&d systems |
| 488-to-005 |
recombinant mouse thrombopoietin (5 ug) |
5 ug |
r&d systems |
| 488-to-005/cf |
recombinant mouse thrombopoietin, cf (5 ug) |
5 ug |
r&d systems |
| 488-to-025 |
recombinant mouse thrombopoietin (25 ug) |
25 ug |
r&d systems |
| 488-to-025/cf |
recombinant mouse thrombopoietin, cf (25 ug) |
25 ug |
r&d systems |
| 4891-025-k |
tacs xtt cell proliferation/viability assay |
2500 tests |
r&d systems |
| 4891-025-k |
tacs xtt cell proliferation/viability assay |
2500 tests |
r&d systems |
| 4892-010-k |
calcein am cell viability assay |
1000 tests |
r&d systems |
| 4892-010-k |
calcein am cell viability assay |
1000 tests |
r&d systems |
| 490-ir-200 |
recombinant mouse il-11 ra/fc chimera (200 ug) |
200 ug |
r&d systems |
| 490-ir-200/cf |
recombinant mouse il-11 ra/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 491-ir-200 |
recombinant mouse il-13 r alpha 1/fc chimera (200 ug) |
200 ug |
r&d systems |
| 491-ir-200/cf |
recombinant mouse il-13 r alpha 1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 492-mm-010 |
recombinant mouse cxcl9/mig (10 ug) |
10 ug |
r&d systems |
| 492-mm-010/cf |
recombinant mouse cxcl9/mig, cf (10 ug) |
10 ug |
r&d systems |
| 492-mm-050 |
recombinant mouse cxcl9/mig (50 ug) |
50 ug |
r&d systems |
| 492-mm-050/cf |
recombinant mouse cxcl9/mig, cf (50 ug) |
50 ug |
r&d systems |
| 493-mv-005 |
recombinant mouse vegf 164 (5 ug) |
5 ug |
r&d systems |
| 493-mv-005/cf |
recombinant mouse vegf 164, cf (5 ug) |
5 ug |
r&d systems |
| 493-mv-025 |
recombinant mouse vegf 164 (25 ug) |
25 ug |
r&d systems |
| 493-mv-025/cf |
recombinant mouse vegf 164, cf (25 ug) |
25 ug |
r&d systems |
| 494-ve-005 |
recombinant mouse vegf 120 (5 ug) |
5 ug |
r&d systems |
| 494-ve-005/cf |
recombinant mouse vegf 120, cf (5 ug) |
5 ug |
r&d systems |
| 494-ve-025 |
recombinant mouse vegf 120 (25 ug) |
25 ug |
r&d systems |
| 494-ve-025/cf |
recombinant mouse vegf 120, cf (25 ug) |
25 ug |
r&d systems |
| 495-mo-025 |
recombinant mouse oncostatin m (osm) (25 ug) |
25 ug |
r&d systems |
| 495-mo-025/cf |
recombinant mouse oncostatin m (osm), cf (25 ug) |
25 ug |
r&d systems |
| 496-eb-200 |
recombinant mouse ephrin-b2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 497-lr-100 |
recombinant mouse leptin r/fc chimera (100 ug) |
100 ug |
r&d systems |
| 497-lr-100/cf |
recombinant mouse leptin r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 498-ob-01m |
recombinant mouse leptin, cf (1 mg) |
1 mg |
r&d systems |
| 498-ob-05m |
recombinant mouse leptin, cf (5 mg) |
5 mg |
r&d systems |
| 499-ml-025 |
recombinant mouse il-12/il-23 p40 homodimer (25 ug) |
25 ug |
r&d systems |
| 499-ml-025/cf |
recombinant mouse il-12/il-23 p40 homodimer, cf (25 ug) |
25 ug |
r&d systems |
| 5-001-a |
normal sheep igg control (1 mg) |
1 mg |
r&d systems |
| 500-rl-005 |
recombinant rat il-1 alpha/il-1f1 (5 ug) |
5 ug |
r&d systems |
| 500-rl-005/cf |
recombinant rat il-1 alpha/il-1f1, cf (5 ug) |
5 ug |
r&d systems |
| 500-rl-025 |
recombinant rat il-1 alpha/il-1f1 (25 ug) |
25 ug |
r&d systems |
| 500-rl-025/cf |
recombinant rat il-1 alpha/il-1f1, cf (25 ug) |
25 ug |
r&d systems |
| 501-rl-010 |
recombinant rat il-1 beta/il-1f2 (10 ug) |
10 ug |
r&d systems |
| 501-rl-010/cf |
recombinant rat il-1 beta/il-1f2, cf (10 ug) |
10 ug |
r&d systems |
| 501-rl-050 |
recombinant rat il-1 beta/il-1f2 (50 ug) |
50 ug |
r&d systems |
| 501-rl-050/cf |
recombinant rat il-1 beta/il-1f2, cf (50 ug) |
50 ug |
r&d systems |
| 502-rl-010 |
recombinant rat il-2 (10 ug) |
10 ug |
r&d systems |
| 502-rl-010/cf |
recombinant rat il-2, cf (10 ug) |
10 ug |
r&d systems |
| 502-rl-050 |
recombinant rat il-2 (50 ug) |
50 ug |
r&d systems |
| 502-rl-050/cf |
recombinant rat il-2, cf (50 ug) |
50 ug |
r&d systems |
| 503-cx-025 |
recombinant mouse cxcl16 (25 ug) |
25 ug |
r&d systems |
| 503-cx-025/cf |
recombinant mouse cxcl16, cf (25 ug) |
25 ug |
r&d systems |
| 504-rl-005 |
recombinant rat il-4 (5 ug) |
5 ug |
r&d systems |
| 504-rl-005/cf |
recombinant rat il-4, cf (5 ug) |
5 ug |
r&d systems |
| 504-rl-025 |
recombinant rat il-4 (25 ug) |
25 ug |
r&d systems |
| 504-rl-025/cf |
recombinant rat il-4, cf (25 ug) |
25 ug |
r&d systems |
| 505-pr-100 |
recombinant human bmpr-ib/alk-6/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 506-rl-010 |
recombinant rat il-6 (10 ug) |
10 ug |
r&d systems |
| 506-rl-010/cf |
recombinant rat il-6, cf (10 ug) |
10 ug |
r&d systems |
| 506-rl-050 |
recombinant rat il-6 (50 ug) |
50 ug |
r&d systems |
| 506-rl-050/cf |
recombinant rat il-6, cf (50 ug) |
50 ug |
r&d systems |
| 507-bp-020 |
recombinant human bmp-6 (20 ug) |
20 ug |
r&d systems |
| 507-bp-020/cf |
recombinant human bmp-6, cf (20 ug) |
20 ug |
r&d systems |
| 508-ck-025 |
recombinant human ccl23/ck beta 8-1 (aa 46-137) (25 ug) |
25 ug |
r&d systems |
| 508-ck-025/cf |
recombinant human ccl23/ck beta 8-1 (aa 46-137), cf (25 ug) |
25 ug |
r&d systems |
| 509-mi-025 |
recombinant human ccl3l1/mip-1 alpha isoform ld78 beta (25 ug) |
25 ug |
r&d systems |
| 509-mi-025/cf |
recombinant human ccl3l1/mip-1 alpha isoform ld78 beta, cf (25 ug) |
25 ug |
r&d systems |
| 510-rt-010 |
recombinant rat tnf-alpha/tnfsf1a (10 ug) |
10 ug |
r&d systems |
| 510-rt-010/cf |
recombinant rat tnf-alpha/tnfsf2, cf (10 ug) |
10 ug |
r&d systems |
| 510-rt-050 |
recombinant rat tnf-alpha/tnfsf1a (50 ug) |
50 ug |
r&d systems |
| 510-rt-050/cf |
recombinant rat tnf-alpha/tnfsf2, cf (50 ug) |
50 ug |
r&d systems |
| 511-mm-010 |
recombinant human mmp-13, cf (10 ug) |
10 ug |
r&d systems |
| 512-gf-010 |
recombinant rat gdnf (10 ug) |
10 ug |
r&d systems |
| 512-gf-010/cf |
recombinant rat gdnf, cf (10 ug) |
10 ug |
r&d systems |
| 512-gf-050 |
recombinant rat gdnf (50 ug) |
50 ug |
r&d systems |
| 512-gf-050/cf |
recombinant rat gdnf, cf (50 ug) |
50 ug |
r&d systems |
| 513-mp-010 |
recombinant human mmp-3, cf (10 ug) |
10 ug |
r&d systems |
| 514-cd-050 |
recombinant human scd4 (50 ug) |
50 ug |
r&d systems |
| 514-cd-050/cf |
recombinant human scd4, cf (50 ug) |
50 ug |
r&d systems |
| 515-cn-010 |
recombinant rat cinc-1 (10 ug) |
10 ug |
r&d systems |
| 515-cn-010/cf |
recombinant rat cinc-1, cf (10 ug) |
10 ug |
r&d systems |
| 515-cn-050 |
recombinant rat cinc-1 (50 ug) |
50 ug |
r&d systems |
| 515-cn-050/cf |
recombinant rat cinc-1, cf (50 ug) |
50 ug |
r&d systems |
| 516-ca-025 |
recombinant rat cinc-2 alpha (25 ug) |
25 ug |
r&d systems |
| 516-ca-025/cf |
recombinant rat cinc-2 alpha, cf (25 ug) |
25 ug |
r&d systems |
| 517-cb-025 |
recombinant rat cinc-2 beta (25 ug) |
25 ug |
r&d systems |
| 517-cb-025/cf |
recombinant rat cinc-2 beta, cf (25 ug) |
25 ug |
r&d systems |
| 518-gm-005 |
recombinant rat gm-csf (5 ug) |
5 ug |
r&d systems |
| 518-gm-005/cf |
recombinant rat gm-csf, cf (5 ug) |
5 ug |
r&d systems |
| 518-gm-025 |
recombinant rat gm-csf (25 ug) |
25 ug |
r&d systems |
| 518-gm-025/cf |
recombinant rat gm-csf, cf (25 ug) |
25 ug |
r&d systems |
| 520-bb-050 |
recombinant rat pdgf-bb (50 ug) |
50 ug |
r&d systems |
| 520-bb-050/cf |
recombinant rat pdgf-bb, cf (50 ug) |
50 ug |
r&d systems |
| 521-rl-025 |
recombinant rat il-18/il-1f4 (25 ug) |
25 ug |
r&d systems |
| 521-rl-025/cf |
recombinant rat il-18/il-1f4, cf (25 ug) |
25 ug |
r&d systems |
| 522-rl-005 |
recombinant rat il-10 (5 ug) |
5 ug |
r&d systems |
| 522-rl-005/cf |
recombinant rat il-10, cf (5 ug) |
5 ug |
r&d systems |
| 522-rl-025 |
recombinant rat il-10 (25 ug) |
25 ug |
r&d systems |
| 522-rl-025/cf |
recombinant rat il-10, cf (25 ug) |
25 ug |
r&d systems |
| 523-st-100 |
recombinant human il-1 r4/st2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 524-gr-050 |
recombinant mouse gitr/tnfrsf18/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 525-c3-025 |
recombinant rat cinc-3 (25 ug) |
25 ug |
r&d systems |
| 525-c3-025/cf |
recombinant rat cinc-3, cf (25 ug) |
25 ug |
r&d systems |
| 526-sa-050 |
recombinant mouse fas ligand/tnfsf6 (50 ug) |
50 ug |
r&d systems |
| 526-sa-050/cf |
recombinant mouse fas ligand/tnfsf6, cf (50 ug) |
50 ug |
r&d systems |
| 527-me-100 |
recombinant mouse hgf r/c-met/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 528-mp-025 |
recombinant mouse ccl24/eotaxin-2/mpif-2 (25 ug) |
25 ug |
r&d systems |
| 528-mp-025/cf |
recombinant mouse ccl24/eotaxin-2/mpif-2, cf (25 ug) |
25 ug |
r&d systems |
| 529-tr-025 |
recombinant mouse ccl17/tarc (25 ug) |
25 ug |
r&d systems |
| 529-tr-025/cf |
recombinant mouse ccl17/tarc, cf (25 ug) |
25 ug |
r&d systems |
| 530-mr-100 |
recombinant mouse il-4 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 531-pa-100 |
recombinant mouse upar/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 532-r2-050 |
recombinant mouse tgf-beta rii(human)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 533-vi-025 |
recombinant mouse ccl28 (25 ug) |
25 ug |
r&d systems |
| 533-vi-025/cf |
recombinant mouse ccl28, cf (25 ug) |
25 ug |
r&d systems |
| 535-in-025 |
recombinant porcine cxcl8/il-8 (25 ug) |
25 ug |
r&d systems |
| 535-in-025/cf |
recombinant porcine cxcl8/il-8, cf (25 ug) |
25 ug |
r&d systems |
| 536-fr-025 |
recombinant rat cx3cl1/fractalkine (25 ug) |
25 ug |
r&d systems |
| 536-fr-025/cf |
recombinant rat cx3cl1/fractalkine, cf (25 ug) |
25 ug |
r&d systems |
| 537-ft-025 |
recombinant rat cx3cl1/fractalkine (chemokine domain) (25 ug) |
25 ug |
r&d systems |
| 537-ft-025/cf |
recombinant rat cx3cl1/fractalkine (chemokine domain), cf (25 ug) |
25 ug |
r&d systems |
| 539-ir-100 |
recombinant mouse il-13 r alpha 2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 540-rm-025 |
recombinant rat ccl20/mip-3 alpha (25 ug) |
25 ug |
r&d systems |
| 540-rm-025/cf |
recombinant rat ccl20/mip-3 alpha, cf (25 ug) |
25 ug |
r&d systems |
| 541-a5-200 |
recombinant rat epha5/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 543-rl-025 |
recombinant rat lix (25 ug) |
25 ug |
r&d systems |
| 543-rl-025/cf |
recombinant rat lix, cf (25 ug) |
25 ug |
r&d systems |
| 545-rl-010 |
recombinant rat il-5 (10 ug) |
10 ug |
r&d systems |
| 545-rl-010/cf |
recombinant rat il-5, cf (10 ug) |
10 ug |
r&d systems |
| 546-tr-050 |
recombinant mouse tslp r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 547-rl-010 |
recombinant rat il-10 (cys 167 tyr) (10 ug) |
10 ug |
r&d systems |
| 547-rl-010/cf |
recombinant rat il-10 (cys 167 tyr), cf (10 ug) |
10 ug |
r&d systems |
| 548-mm-010 |
recombinant mouse mmp-3, cf (10 ug) |
10 ug |
r&d systems |
| 549-r3-100 |
recombinant mouse il-3 r beta/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 550-ag-100 |
recombinant rat agrin (100 ug) |
100 ug |
r&d systems |
| 550-ag-100/cf |
recombinant rat agrin, cf (100 ug) |
100 ug |
r&d systems |
| 551-mr-100 |
recombinant mouse il-15 r alpha/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 552-r1-010 |
recombinant cotton rat il-1 alpha/il-1f1 (10 ug) |
10 ug |
r&d systems |
| 552-r1-010/cf |
recombinant cotton rat il-1 alpha/il-1f1, cf (10 ug) |
10 ug |
r&d systems |
| 555-ts-010 |
recombinant mouse tslp (10 ug) |
10 ug |
r&d systems |
| 555-ts-010/cf |
recombinant mouse tslp, cf (10 ug) |
10 ug |
r&d systems |
| 556-ng-100 |
recombinant rat beta-ngf (100 ug) |
100 ug |
r&d systems |
| 556-ng-100/cf |
recombinant rat beta-ngf, cf (100 ug) |
100 ug |
r&d systems |
| 557-nt-010 |
recombinant rat cntf (10 ug) |
10 ug |
r&d systems |
| 557-nt-010/cf |
recombinant rat cntf, cf (10 ug) |
10 ug |
r&d systems |
| 557-nt-050 |
recombinant rat cntf (50 ug) |
50 ug |
r&d systems |
| 557-nt-050/cf |
recombinant rat cntf, cf (50 ug) |
50 ug |
r&d systems |
| 558-cr-050 |
recombinant rat cntf sr alpha (50 ug) |
50 ug |
r&d systems |
| 558-cr-050/cf |
recombinant rat cntf sr alpha, cf (50 ug) |
50 ug |
r&d systems |
| 560-gr-100/cf |
recombinant rat gfr alpha-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 561-r6-025 |
recombinant cotton rat il-6 (25 ug) |
25 ug |
r&d systems |
| 561-r6-025/cf |
recombinant cotton rat il-6, cf (25 ug) |
25 ug |
r&d systems |
| 563-mr-100 |
recombinant mouse il-1 rii/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 564-rv-010 |
recombinant rat vegf 164 (10 ug) |
10 ug |
r&d systems |
| 564-rv-010/cf |
recombinant rat vegf 164, cf (10 ug) |
10 ug |
r&d systems |
| 564-rv-050 |
recombinant rat vegf 164 (50 ug) |
50 ug |
r&d systems |
| 564-rv-050/cf |
recombinant rat vegf 164, cf (50 ug) |
50 ug |
r&d systems |
| 565-rg-025 |
recombinant cotton rat ifn-gamma (25 ug) |
25 ug |
r&d systems |
| 565-rg-025/cf |
recombinant cotton rat ifn-gamma, cf (25 ug) |
25 ug |
r&d systems |
| 566-n1-025 |
recombinant rat neuropilin-1/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 566-nns-025 |
recombinant rat neuropilin-1/fc chimera (nso-expressed), cf (25 ug) |
25 ug |
r&d systems |
| 567-n2-025 |
recombinant rat neuropilin-2/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 568-fr-025 |
recombinant rat cx3cl1/fractalkine (aa 22100) (25 ug) |
25 ug |
r&d systems |
| 568-fr-025/cf |
recombinant rat cx3cl1/fractalkine (aa 22100), cf (25 ug) |
25 ug |
r&d systems |
| 569-a4-200 |
recombinant mouse ephrin-a4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 571-mf-025 |
recombinant mouse cx3cl1/fractalkine (aa 25-105) (25 ug) |
25 ug |
r&d systems |
| 571-mf-025/cf |
recombinant mouse cx3cl1/fractalkine (aa 25-105), cf (25 ug) |
25 ug |
r&d systems |
| 572-mc-025 |
recombinant mouse cxcl11/i-tac (25 ug) |
25 ug |
r&d systems |
| 572-mc-025/cf |
recombinant mouse cxcl11/i-tac, cf (25 ug) |
25 ug |
r&d systems |
| 573-rp-100 |
recombinant rat il-1 r6/il-1 r rp2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 574-cd-050 |
recombinant mouse cd27/tnfrsf7/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 575-es-100 |
recombinant mouse e-selectin (cd62e)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 576-ls-100 |
recombinant mouse l-selectin/cd62l/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 577-a7-100 |
recombinant rat alk-7/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 578-b5-025 |
recombinant mouse igfbp-5, cf (25 ug) |
25 ug |
r&d systems |
| 579-r2-020 |
recombinant cotton rat il-2 (20 ug) |
20 ug |
r&d systems |
| 579-r2-020/cf |
recombinant cotton rat il-2, cf (20 ug) |
20 ug |
r&d systems |
| 580-rt-010 |
recombinant rat timp-1, cf (10 ug) |
10 ug |
r&d systems |
| 581-cr-010 |
recombinant cotton rat il-10 (cys 149 tyr) (10 ug) |
10 ug |
r&d systems |
| 581-cr-010/cf |
recombinant cotton rat il-10 (tyr), cf (10 ug) |
10 ug |
r&d systems |
| 582-ml-010 |
recombinant mouse il-22 (10 ug) |
10 ug |
r&d systems |
| 582-ml-010/cf |
recombinant mouse il-22, cf (10 ug) |
10 ug |
r&d systems |
| 583-ic-050 |
recombinant rat icam-1/cd54/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 584-r4-010 |
recombinant cotton rat il-4 (10 ug) |
10 ug |
r&d systems |
| 584-r4-010/cf |
recombinant cotton rat il-4, cf (10 ug) |
10 ug |
r&d systems |
| 585-if-100 |
recombinant rat ifn-gamma (100 ug) |
100 ug |
r&d systems |
| 585-if-100/cf |
recombinant rat ifn-gamma, cf (100 ug) |
100 ug |
r&d systems |
| 587-ri-050 |
recombinant mouse tgf-beta ri/alk-5/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 588-pl-025 |
recombinant porcine il-18/il-1f4 (25 ug) |
25 ug |
r&d systems |
| 588-pl-025/cf |
recombinant porcine il-18/il-1f4, cf (25 ug) |
25 ug |
r&d systems |
| 591-mr-100 |
recombinant mouse mer/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 592-fr-010 |
recombinant mouse sfrp-3 (10 ug) |
10 ug |
r&d systems |
| 592-fr-010/cf |
recombinant mouse sfrp-3, cf (10 ug) |
10 ug |
r&d systems |
| 593-bc-050 |
recombinant mouse bcma/tnfrsf17/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 594-ml-010 |
recombinant mouse il-21 (10 ug) |
10 ug |
r&d systems |
| 594-ml-010/cf |
recombinant mouse il-21, cf (10 ug) |
10 ug |
r&d systems |
| 595-p4-025 |
recombinant mouse cxcl4/pf4, cf (25 ug) |
25 ug |
r&d systems |
| 596-mr-100 |
recombinant mouse il-21 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 597-lm-010 |
recombinant mouse limitin/fc chimera, cf (10 ug) |
10 ug |
r&d systems |
| 598-lp-01m |
recombinant rat leptin, cf (1 mg) |
1 mg |
r&d systems |
| 598-lp-05m |
recombinant rat leptin, cf (5 mg) |
5 mg |
r&d systems |
| 599-jg-100 |
recombinant rat jagged 1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 6-001-a |
normal rat igg control (1 mg) |
1 mg |
r&d systems |
| 600-va-025 |
recombinant viral mip-i (25 ug) |
25 ug |
r&d systems |
| 600-va-025/cf |
recombinant viral mip-i, cf (25 ug) |
25 ug |
r&d systems |
| 601-vb-025 |
recombinant viral mip-ii (25 ug) |
25 ug |
r&d systems |
| 601-vb-025/cf |
recombinant viral mip-ii, cf (25 ug) |
25 ug |
r&d systems |
| 602-a1-200 |
recombinant mouse ephrin-a1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 603-a2-200 |
recombinant mouse ephrin-a2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 604-4r-050 |
recombinant human il-4 r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 607-a6-200 |
recombinant mouse epha6/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 608-a7-200 |
recombinant mouse epha7/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 611-b6-200 |
recombinant mouse ephb6/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 612-cd-010 |
recombinant human cardiotrophin-1 (ct-1) (10 ug) |
10 ug |
r&d systems |
| 612-cd-010/cf |
recombinant human cardiotrophin-1 (ct-1), cf (10 ug) |
10 ug |
r&d systems |
| 612-cd-050 |
recombinant human cardiotrophin-1 (ct-1) (50 ug) |
50 ug |
r&d systems |
| 612-cd-050/cf |
recombinant human cardiotrophin-1 (ct-1), cf (50 ug) |
50 ug |
r&d systems |
| 613-fr-100 |
recombinant human gfr alpha-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 614-ins-100 |
recombinant human il-13 r alpha 2/fc chimera, (nso), cf (100 ug) |
100 ug |
r&d systems |
| 614-ir-100 |
recombinant human il-13 r alpha 2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 615-bm-050 |
recombinant human bmp-5 (50 ug) |
50 ug |
r&d systems |
| 615-bm-050/cf |
recombinant human bmp-5, cf (50 ug) |
50 ug |
r&d systems |
| 617-cl-050 |
recombinant human cd40 ligand/tnfsf5 (aa 108-261) (50 ug) |
50 ug |
r&d systems |
| 617-cl-050/cf |
recombinant human cd40 ligand/tnfsf5 (aa 108-261), cf (50 ug) |
50 ug |
r&d systems |
| 618-il-010 |
recombinant human cxcl8/il-8 (endothelial cell derived) (10 ug) |
10 ug |
r&d systems |
| 618-il-010/cf |
recombinant human cxcl8/il-8 (endothelial cell derived), cf (10 ug) |
10 ug |
r&d systems |
| 618-il-050 |
recombinant human cxcl8/il-8 (endothelial cell derived) (50 ug) |
50 ug |
r&d systems |
| 618-il-050/cf |
recombinant human cxcl8/il-8 (endothelial cell derived), cf (50 ug) |
50 ug |
r&d systems |
| 619-ti-100 |
recombinant human tie-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 620-cm-025 |
recombinant viral cmv ul146/vcxc1 (25 ug) |
25 ug |
r&d systems |
| 620-cm-025/cf |
recombinant viral cmv ul146/vcxc1, cf (25 ug) |
25 ug |
r&d systems |
| 622-vd-005 |
recombinant human vegf-d (5 ug) |
5 ug |
r&d systems |
| 622-vd-005/cf |
recombinant human vegf-d, cf (5 ug) |
5 ug |
r&d systems |
| 622-vd-025 |
recombinant human vegf-d (25 ug) |
25 ug |
r&d systems |
| 622-vd-025/cf |
recombinant human vegf-d, cf (25 ug) |
25 ug |
r&d systems |
| 623-an-025 |
recombinant human angiopoietin-2 (25 ug) |
25 ug |
r&d systems |
| 623-an-025/cf |
recombinant human angiopoietin-2, cf (25 ug) |
25 ug |
r&d systems |
| 627-cd-100 |
recombinant human cd6/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 628-lk-025 |
recombinant human ccl15/mip-1 delta/lkn-1 (68 aa) (25 ug) |
25 ug |
r&d systems |
| 628-lk-025/cf |
recombinant human ccl15/mip-1 delta/lkn-1 (68 aa), cf (25 ug) |
25 ug |
r&d systems |
| 629-lr-100 |
recombinant human lymphotoxin beta r (ltbr)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 630-tr-100 |
recombinant human trail r3/tnfrsf10c/fc chimera (100 ug) |
100 ug |
r&d systems |
| 630-tr-100/cf |
recombinant human trail r3/tnfrsf10c/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 631-t2-100 |
recombinant human trail r2/tnfrsf10b/fc chimera (100 ug) |
100 ug |
r&d systems |
| 631-t2-100/cf |
recombinant human trail r2/tnfrsf10b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 633-tr-100 |
recombinant human trail r4/tnfrsf10d/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 634-ag-100 |
recombinant mouse agrp c-terminal fragment, cf |
100 µg |
r&d systems |
| 634-ag-100 |
recombinant mouse agrp c-terminal fragment, cf (100 ug) |
100 ug |
r&d systems |
| 635-ms-025 |
recombinant human msp beta chain (25 ug) |
25 ug |
r&d systems |
| 635-ms-025/cf |
recombinant human msp beta chain, cf (25 ug) |
25 ug |
r&d systems |
| 636-ag-100 |
recombinant mouse agrp c-terminal fragment, cf (100 ug) |
100 ug |
r&d systems |
| 636-r1-025 |
recombinant human stnf ri/tnfrsf1a (25 ug) |
25 ug |
r&d systems |
| 636-r1-025/cf |
recombinant human soluble tnf ri/tnfrsf1a, cf (25 ug) |
25 ug |
r&d systems |
| 637-ar-100 |
recombinant human activin ria/alk-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 638-a1-200 |
recombinant human epha1/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 639-a2-200 |
recombinant mouse epha2/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 640-a3-200 |
recombinant mouse epha3/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 641-a4-200 |
recombinant mouse epha4/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 643-vm-050 |
recombinant mouse vcam-1/cd106/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 643-vm-200 |
recombinant mouse vcam-1/cd106/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 645-wn-010 |
recombinant mouse wnt-5a (10 ug) |
10 ug |
r&d systems |
| 645-wn-010/cf |
recombinant mouse wnt-5a, cf (10 ug) |
10 ug |
r&d systems |
| 648-ec-100 |
recombinant human e-cadherin/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 649-en-025 |
recombinant human cxcl5/ena-70 (25 ug) |
25 ug |
r&d systems |
| 649-en-025/cf |
recombinant human cxcl5/ena-70, cf (25 ug) |
25 ug |
r&d systems |
| 650-t2-100 |
recombinant human trop-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 651-na-025 |
recombinant human cxcl5/ena-74 (25 ug) |
25 ug |
r&d systems |
| 651-na-025/cf |
recombinant human cxcl5/ena-74, cf (25 ug) |
25 ug |
r&d systems |
| 652-p2-020 |
recombinant porcine il-2 (20 ug) |
20 ug |
r&d systems |
| 652-p2-020/cf |
recombinant porcine il-2, cf (20 ug) |
20 ug |
r&d systems |
| 653-e3-025 |
recombinant human ccl26/eotaxin-3 (25 ug) |
25 ug |
r&d systems |
| 653-e3-025/cf |
recombinant human ccl26/eotaxin-3, cf (25 ug) |
25 ug |
r&d systems |
| 654-p4-025 |
recombinant porcine il-4 (25 ug) |
25 ug |
r&d systems |
| 654-p4-025/cf |
recombinant porcine il-4, cf (25 ug) |
25 ug |
r&d systems |
| 655-fr-050 |
recombinant human fgf r1 alpha (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 656-al-100 |
recombinant human alcam/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 658-fr-050 |
recombinant human fgf r1 alpha (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 659-ab-005 |
recombinant human activin b (5 ug) |
5 ug |
r&d systems |
| 659-ab-005/cf |
recombinant human activin b, cf (5 ug) |
5 ug |
r&d systems |
| 659-ab-025 |
recombinant human activin b (25 ug) |
25 ug |
r&d systems |
| 659-ab-025/cf |
recombinant human activin b, cf (25 ug) |
25 ug |
r&d systems |
| 661-fr-050 |
recombinant human fgf r1 beta (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 662-or-100 |
recombinant mouse osm r beta/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 663-fr-050 |
recombinant human fgf r2 alpha (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 664-li-025 |
recombinant human light/tnfsf14 (25 ug) |
25 ug |
r&d systems |
| 664-li-025/cf |
recombinant human light/tnfsf14, cf (25 ug) |
25 ug |
r&d systems |
| 665-fr-050 |
recombinant human fgf r2 beta (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 666-dn-050 |
recombinant human dnam-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 669-fo-025 |
recombinant human follistatin (25 ug) |
25 ug |
r&d systems |
| 669-fo-025/cf |
recombinant human follistatin, cf (25 ug) |
25 ug |
r&d systems |
| 670-fr-100 |
recombinant human gfr alpha-3/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 671-gp-100 |
recombinant human gp130/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 672-it-025 |
recombinant human cxcl11/i-tac (25 ug) |
25 ug |
r&d systems |
| 672-it-025/cf |
recombinant human cxcl11/i-tac, cf (25 ug) |
25 ug |
r&d systems |
| 673-ir-100 |
recombinant human ifn-gamma r1 (100 ug) |
100 ug |
r&d systems |
| 673-ir-100/cf |
recombinant human ifn-gamma r1, cf (100 ug) |
100 ug |
r&d systems |
| 674-b2-025 |
recombinant human igfbp-2, cf (25 ug) |
25 ug |
r&d systems |
| 675-b3-025 |
recombinant human igfbp-3, cf (25 ug) |
25 ug |
r&d systems |
| 676-cp-100 |
recombinant human il-1 r3/il-1 r acp/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 678-ly-010 |
recombinant human lymphotoxin alpha1/beta2 (10 ug) |
10 ug |
r&d systems |
| 678-ly-010/cf |
recombinant human lymphotoxin alpha1/beta2, cf (10 ug) |
10 ug |
r&d systems |
| 679-tx-010 |
recombinant human lymphotoxin alpha2/beta1 (10 ug) |
10 ug |
r&d systems |
| 679-tx-010/cf |
recombinant human lymphotoxin alpha2/beta1, cf (10 ug) |
10 ug |
r&d systems |
| 680-pi-010 |
recombinant porcine il-1 alpha/il-1f1 (10 ug) |
10 ug |
r&d systems |
| 680-pi-010/cf |
recombinant porcine il-1 alpha/il-1f1, cf (10 ug) |
10 ug |
r&d systems |
| 681-pi-010 |
recombinant porcine il-1 beta/il-1f2 (10 ug) |
10 ug |
r&d systems |
| 681-pi-010/cf |
recombinant porcine il-1 beta/il-1f2, cf (10 ug) |
10 ug |
r&d systems |
| 682-pl-050 |
recombinant human prolactin, cf (50 ug) |
50 ug |
r&d systems |
| 683-rk-100 |
recombinant human rank/tnfrsf11a/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 684-fr-050 |
recombinant human fgf r2 beta (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 685-fr-050 |
recombinant human fgf r4/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 686-pi-025 |
recombinant porcine il-6 (25 ug) |
25 ug |
r&d systems |
| 686-pi-025/cf |
recombinant porcine il-6, cf (25 ug) |
25 ug |
r&d systems |
| 688-tk-100 |
recombinant human trkb/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 689-gr-100 |
recombinant human gitr/tnfrsf18/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 690-pt-025 |
recombinant porcine tnf-alpha/tnfsf1a (25 ug) |
25 ug |
r&d systems |
| 690-pt-025/cf |
recombinant porcine tnf-alpha/tnfsf2, cf (25 ug) |
25 ug |
r&d systems |
| 692-rk-100 |
recombinant mouse rank/tnfrsf11a/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 693-pi-010 |
recombinant porcine il-10 (10 ug) |
10 ug |
r&d systems |
| 693-pi-010/cf |
recombinant porcine il-10, cf (10 ug) |
10 ug |
r&d systems |
| 694-gl-025 |
recombinant human gitr ligand/tnfsf18 (25 ug) |
25 ug |
r&d systems |
| r&d systems 产品目录列表 page 5 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
400 8700 545
400 8700 545
